Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy

Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy

Sarcoma is one of the most severe forms of pediatric cancer and current therapies -chemotherapy and surgery- fail to eradicate the disease in half of patients. Preclinical studies combining new therapeutic approaches can be useful to design better therapies. On one hand, it is known that CXCR4 expre...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Maria Vela, David Bueno, Pablo González-Navarro, Ariadna Brito, Lucía Fernández, Adela Escudero, Jaime Valentín, Carmen Mestre-Durán, Marina Arranz-Álvarez, Rebeca Pérez de Diego, Marta Mendiola, José Juan Pozo-Kreilinger, Antonio Pérez-Martínez
Format: Article
Sprog:English
Udgivet: Frontiers Media S.A. 2019-08-01
Serier:Frontiers in Immunology
Fag:
sarcoma
metastasis
chemokine C-X-C receptor 4 (CXCR4)
therapeutic antibody
activated and expanded natural killer (NKAE) cells
immunotherapy
Online adgang:https://www.frontiersin.org/article/10.3389/fimmu.2019.01814/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.01814/full

Lignende værker